Results 51 to 60 of about 9,528 (197)

Surgical outcomes of patients at prohibitive risk who are reconsidered for surgeryCentral MessagePerspective

JTCVS Open, 2023
Objectives: Transcatheter treatment of advanced mitral and tricuspid valve disease is largely limited to patients at prohibitive surgical risk, although many are not candidates for transcatheter treatment.
Catherine M. Wagner, MD, Megan L. Schultz, MD, Alexander A. Brescia, MD, MSc, Yoyo Wang, BS, Whitney Fu, MD, Robert B. Hawkins, MD, MSc, Matthew A. Romano, MD, Gorav Ailawadi, MD, MBA, Steven F. Bolling, MD   +8 more
doaj   +1 more source

Case report: Self-expanding transcatheter valve implantation (Acurate Neo 2) in a very small native aortic annulus

Frontiers in Cardiovascular Medicine, 2023
Transcatheter aortic valve replacement (TAVR) is a treatment of choice in patients with symptomatic severe aortic valve stenosis (AS) and intermediate-to-high surgical risk.
Massimo Medda, Francesco Casilli, Marta Bande, Maurizio Tespili, Francesco Donatelli   +4 more
doaj   +1 more source

Echocardiographic Imaging to Guide Tricuspid Interventions

Structural Heart
Transcatheter tricuspid valve interventions may offer patients less invasive treatment alternatives to surgery. This review evaluates the use of echocardiography to determine anatomic suitability and guide the 2 most common classes of device currently ...
Rebecca T. Hahn, MD
doaj   +1 more source

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring Replacement

, 2019
Transcatheter aortic and pulmonary valves have been used to treat stenosis or regurgitation after prior surgical tricuspid valve (TV) replacement or repair.
Kreutzer, Jacqueline N., Cabalka, Allison K., Whisenant, Brian, El-Said, Howaida, Dvir, Danny, Hainstock, Michael R., Hainstock, Michael R, Torres, Alejandro J, Martin, Mary H., Rudolph, Tanja, Hildick-Smith, David, Aboulhosn, Jamil A., Guerrero, Mayra E, Delaney, Jeffrey W., Kornowski, Ran, Thomson, John D.R., Tzifa, Aphrodite, Delaney, Jeffrey W, Kreutzer, Jacqueline N, Cabalka, Allison K, Finkelstein, Ariel, Latib, Azeem, Cheema, Asim N, Eicken, Andreas, Cheema, Asim N., McElhinney, Doff B., Torres, Alejandro J., Gewillig, Marc, Zhang, Yulin, Schubert, Stephan, Thomson, John D R, Guerrero, Mayra E., Ribichini, Flavio, Salizzoni, Stefano, McElhinney, Doff B, George, Isaac, Alvarez-Fuente, Maria, Meadows, Jeffery, Martin, Mary H, Aboulhosn, Jamil A, Lamers, Luke   +40 more
core   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Resurgence of the Tricuspid Valve: A Comprehensive Review of Transcatheter Interventions

Indian Journal of Clinical Cardiology
Tricuspid valve, once considered a “forgotten valve,” is experiencing a remarkable resurgence in clinical practice. Previously viewed as a secondary consequence of left-sided heart disease, tricuspid regurgitation is now recognized as an independent ...
Krishna Santhosh Vemuri, Tejaswi Penta, Deepak Sherpally, Bhavanadhar Penta   +3 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source

Advances in transcatheter mitral and tricuspid therapies

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +1 more source